Kiely Patrick D W, Brown Andrew K, Edwards Christopher J, O'Reilly David T, Ostör Andrew J K, Quinn Mark, Taggart Allister, Taylor Peter C, Wakefield Richard J, Conaghan Philip G
Department of Rheumatology, St Georges Healthcare NHS Trust, London, UK.
Rheumatology (Oxford). 2009 Jul;48(7):765-72. doi: 10.1093/rheumatology/kep073. Epub 2009 Apr 28.
RA has a substantial impact on both patients and healthcare systems. Our objective is to advance the understanding of modern management principles in light of recent evidence concerning the condition's diagnosis and treatment.
A group of practicing UK rheumatologists formulated contemporary management principles and clinical practice recommendations concerning both diagnosis and treatment. Areas of clinical uncertainty were documented, leading to research recommendations.
A fundamental concept governing treatment of RA is minimization of cumulative inflammation, referred to as the inflammation-time area under the curve (AUC). To achieve this, four core principles of management were identified: (i) detect and refer patients early, even if the diagnosis is uncertain: patients should be referred at the first suspicion of persistent inflammatory polyarthritis and rheumatology departments should provide rapid access to a diagnostic and prognostic service; (ii) treat RA immediately: optimizing outcomes with conventional DMARDs and biologics requires that effective treatment be started early-ideally within 3 months of symptom onset; (iii) tight control of inflammation in RA improves outcome: frequent assessments and an objective protocol should be used to make treatment changes that maintain low-disease activity/remission at an agreed target; (iv) consider the risk-benefit ratio and tailor treatment to each patient: differing patient, disease and drug characteristics require long-term monitoring of risks and benefits with adaptations of treatments to suit individual circumstances.
These principles focus on effective control of the inflammatory process in RA, but optimal uptake may require changes in service provision to accommodate appropriate care pathways.
类风湿关节炎(RA)对患者和医疗保健系统均有重大影响。我们的目标是根据有关该疾病诊断和治疗的最新证据,增进对现代管理原则的理解。
一组英国执业风湿病学家制定了有关诊断和治疗的当代管理原则及临床实践建议。记录了临床不确定性领域,从而得出研究建议。
RA治疗的一个基本概念是将累积炎症降至最低,即炎症-时间曲线下面积(AUC)。为实现这一目标,确定了四个核心管理原则:(i)尽早发现并转诊患者,即使诊断不确定:患者一旦首次怀疑患有持续性炎性多关节炎就应转诊,风湿病科应提供快速的诊断和预后服务;(ii)立即治疗RA:使用传统改善病情抗风湿药(DMARDs)和生物制剂优化治疗效果需要尽早开始有效治疗——理想情况是在症状出现后3个月内;(iii)严格控制RA中的炎症可改善预后:应通过频繁评估和客观方案来调整治疗,以在商定目标下维持低疾病活动度/缓解状态;(iv)考虑风险效益比并为每位患者量身定制治疗方案:不同的患者、疾病和药物特征需要长期监测风险和效益,并根据个体情况调整治疗方案。
这些原则侧重于有效控制RA中的炎症过程,但要实现最佳应用可能需要改变服务提供方式以适应适当的护理途径。